Shout-out here to Immuron. $1.5 billion market opportunity. Immuron's drug is already on the market! Amazon reviews off the charts. Passport Health recommends Travelan as the go-to preventative food & water-borne GI illness drug.
It's all coming together. GSK bought out the company I posted about a day or two ago for $215 million U.S. for a promising Phase 1 Shigella vaccine drug.
Undervalued a bit lol?!
Stock Price Commentary, page-4
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $1.158K | 11.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9352 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 251204 | 4 |
View Market Depth
| Last trade - 10.48am 27/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |